Cosentyx

Who Should Consider Cosentyx? Cosentyx is appropriate for adults who: 

• Have moderate to severe plaque psoriasis and are candidates for systemic therapy or phototherapy.
• Suffer from active psoriatic arthritis.
• Are diagnosed with active ankylosing spondylitis.

How is Cosentyx Administered? Cosentyx is administered as a subcutaneous injection. The typical sites for injection include the thigh, lower abdomen, or upper arms. Patients are usually trained by healthcare professionals on how to self-administer using a pre-filled syringe or pen. The dosing schedule varies based on the condition being treated but generally starts with a loading dose followed by monthly maintenance doses.

Important Information for Cosentyx Users:

• How to Use: Follow the specific instructions provided by your healthcare provider on how to inject Cosentyx.
• Storage: Store Cosentyx in the refrigerator, but do not freeze. Allow the medication to reach room temperature before injecting.
• Side Effects: Common side effects include upper respiratory tract infections, diarrhea, and injection site reactions. Contact your healthcare provider if you experience any severe or unexpected symptoms.
• Monitoring: Regular medical check-ups are recommended to monitor the effectiveness of the treatment and to manage any side effects.

Medication Warnings

• Infections: Cosentyx can lower your immune system’s ability to fight infections. Report any signs of infection, such as fever, chills, or persistent cough, to your healthcare provider immediately.
• Inflammatory Bowel Disease: New cases or exacerbations of inflammatory bowel disease have been reported with Cosentyx. Inform your doctor if you experience any new or worsening stomach pain or diarrhea.
• Allergic Reactions: If you experience symptoms such as rash, hives, swelling of the face, or difficulty breathing, seek immediate medical assistance.
• Vaccinations: Live vaccines should be avoided during treatment with Cosentyx. Discuss your vaccination history with your healthcare provider.

Who Should and Shouldn’t Take Cosentyx?

• Suitable Candidates:
  • Adults with specific chronic inflammatory conditions who require targeted immune modulation.
• Unsuitable Candidates:
  • Individuals with active, severe infections.
  • Patients who have had allergic reactions to secukinumab or any of the other components in Cosentyx.
  • Those with active inflammatory bowel disease unless assessed and managed by a healthcare provider.

For more detailed information and personalized advice, consult your healthcare provider.